Bank Of America Corp Vanda Pharmaceuticals Inc. Call Options Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VNDA
# of Institutions
154Shares Held
45MCall Options Held
132KPut Options Held
220K-
Black Rock Inc. New York, NY8.14MShares$42.2 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.11MShares$21.4 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.43MShares$17.8 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.26MShares$11.7 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.15MShares$11.2 Million1.49% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $294M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...